{"id":"W2128964123","doi":"10.1093/annonc/mdq027","title":"Results of a phase I/II study of ocrelizumab, a fully humanized anti-CD20 mAb, in patients with relapsed/refractory follicular lymphoma","year":2010,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":144,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Rituximab; Internal medicine; Refractory (planetary science); Follicular lymphoma; Gastroenterology; Neutropenia; Adverse effect; Lymphoma; Cohort; Pharmacokinetics; CD20; Toxicity; Phases of clinical research; Oncology; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001197299,0.0002133254,0.001181881,0.0005344402,0.00004390813,0.000002966045,0.0003258777,0.0002774761,0.0001874262],"category_scores_gemma":[0.0008914173,0.0001734365,0.0001095788,0.0005735131,0.0003679349,0.00008491149,0.0001652676,0.0004362072,0.000005374223],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007131648,"about_ca_system_score_gemma":0.0009868981,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001206499,"about_ca_topic_score_gemma":0.0009290901,"domain_scores_codex":[0.9968682,0.0002926726,0.001123715,0.0004380266,0.0008302826,0.0004470981],"domain_scores_gemma":[0.9968837,0.0002669411,0.0006547527,0.0008461792,0.001173595,0.000174764],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1548245,0.2133411,0.3203138,0.0009620527,0.001535984,0.001208782,0.01508383,0.00001828266,0.07767627,0.0002070288,0.01473506,0.2000933],"study_design_scores_gemma":[0.2016475,0.2567454,0.4972364,0.000364475,0.0001487748,0.00001962706,0.000978971,0.00003756288,0.01677473,0.00006046498,0.0256973,0.000288785],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9948375,0.0000992592,0.00000111234,0.0004874733,0.0001426535,0.001498882,0.00006728959,0.00001576425,0.002850067],"genre_scores_gemma":[0.9992664,0.00005727718,0.0002367104,0.000143289,0.00005152953,0.00005203772,0.00003446971,0.00003833371,0.0001199284],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1998045,"threshold_uncertainty_score":0.7072536,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06645319039979994,"score_gpt":0.4201120801170726,"score_spread":0.3536588897172727,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}